Clinical Study Results
Research Sponsor: AstraZeneca KK
Drug studied: Tezepelumab
Study Purpose: This study was done to learn about the safety of tezepelumab in Japanese participants with severe asthma
Protocol Number: D5180C00019

Thank you!
Thank you for taking part in the clinical study for the study drug tezepelumab. You and all of the participants helped researchers learn more about tezepelumab to help people with severe asthma.

AstraZeneca KK sponsored this study and believes it is important to share the results of the study with you and the public. An independent non-profit organization called CISCRP helped prepare this summary of the study results for you. We hope it helps you understand and feel proud of your important role in medical research.

If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.